Cargando…
A novel workflow for cancer blood biomarker identification
BACKGROUND: Over the last few years, great progress has been made in the development of key technologies to detect peripheral blood-based, tumor-specific biomarkers, such as circulating tumor cells (CTCs) and circulating cell free tumor DNA (ctDNA). Despite the considerable advances and their multip...
Autores principales: | Wang, Xiang, Qiu, Zhiqiang, Ji, Xiangwen, Ning, Weihai, An, Yihua, Wang, Shengdian, Zhang, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723582/ https://www.ncbi.nlm.nih.gov/pubmed/33313175 http://dx.doi.org/10.21037/atm-20-2047 |
Ejemplares similares
-
Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma
por: Wang, Xiang, et al.
Publicado: (2020) -
The significance of glycolysis index and its correlations with immune infiltrates in Alzheimer’s disease
por: Qiu, Zhiqiang, et al.
Publicado: (2022) -
A Panel of Synapse-Related Genes as a Biomarker for Gliomas
por: Ji, Xiangwen, et al.
Publicado: (2020) -
Transthyretin as a novel candidate biomarker for preeclampsia
por: ZHU, LEI, et al.
Publicado: (2014) -
Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)